“Infuse”的搜索结果，显示 1-10 项，共有 354 项

1. 血液科- 临床试验- 妙佑医疗国际

   A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma. Rochester, Minn ...

2. 关于 - 妙佑医疗国际

   The cells are grown to much higher numbers in the lab and then infused back into the person's bloodstream. The synthetic CARs allow the T cells to bind to ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma. Rochester, Minn ...

4. 血液科- 临床试验- 妙佑医疗国际

   A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma. Rochester, Minn ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... infused intravenously (IV) on Day 1 of each 28-day cycle (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2). Patients randomized to B+R will receive 6 cycles of ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... infused intravenously (IV) on Day 1 of each 28-day cycle (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2). Patients randomized to B+R will receive 6 cycles of ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn., Jacksonville, Fla. The purpose of this study is to demonstrate pharmacokinetic non-inferiority for nivolumab + relatlimab FDC SC (fixed-dose ...

9. EpicCare Link Community User Quick Start Guide

   Page 1. Page 2. Page 3. Page 4. Page 5. Page 6. Page 7. Page 8. Page 9. Page 10. Page 11. Page 12. Page 13. Page 14. Page 15. Page 16. Page 17. Page 18.

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    ... infused intravenously (IV) on Day 1 of each 28-day cycle (Cycle 1: 375 mg/m2; Cycles 2-6: 500 mg/m2). Patients randomized to B+R will receive 6 cycles of ...